Page 81 - Biomedical Engineering and Design Handbook Volume 2, Applications
P. 81

60  MEDICAL DEVICE DESIGN

           3.2 ARTIFICIAL HEART VALVES AND RELATED TECHNOLOGIES

           3.2.1 Market Size
                       The number of valve replacement operations performed in the United States rose from an estimated
                       60,000 during 1996 (Vongpatanasin et a1., 1996) to more than 78,000 in 2005 (DeFrances et al.,
                       2007). Worldwide, over 350,000 valves are implanted each year, with over 50 percent being mechan-
                       ical, or purely artificial, in design (Butany and Collins, 2005). As access to cardiac surgery becomes
                       more widespread in developing nations, it is expected that the need for durable, safe, low-cost valves
                       will grow considerably (Zilla et al., 2008).


           3.2.2 Indications

                       The medical indications for valve replacement are thoroughly described in a report from the American
                       College of Cardiology/American Heart Association Task Force on Practice Guidelines that addresses
                       the management of patients with valve disease (Bonow et al., 2006). The etiology of valve disease dif-
                       fers, depending on the patient group and the valve location, as does the preferred corrective treatment.
                       In developed nations, the young suffer from congenital valve defects, while older adults exhibit
                       acquired valve disease. Valve replacement can be performed upon all valves of the heart but most cases
                       involve the aortic or mitral valves. Common reasons for native valve replacement are severe stenosis
                       and regurgitation with or without symptoms, which may include chest pain, shortness of breath, and
                       loss of consciousness. The reduction in effective orifice size associated with a stenotic lesion results in
                       a large transvalvular pressure gradient that may exceed 50 mmHg in the aortic position for severe cases
                       (Bonow et al., 1998). In regurgitation, the blood pumped forward into the recipient vessel or ventricle
                       spills back into the adjacent pumping chamber through an incompetent valve, minimizing forward
                       movement. The end effects of chronic stenosis or regurgitation are compensatory anatomic changes
                       that accommodate, for a limited time, the reduced pumping efficiency due to restricted blood move-
                       ment. In general, heart valve replacement is performed when repair is not possible, as the implantation
                       of an artificial heart valve brings with it another set of problems. Total replacement and removal of
                       native valve components in the mitral position is particularly limited, as the mitral valve is anatomi-
                       cally and functionally integral to the left ventricle (David et al., 1983; Yun et al., 1999). Concomitant
                       illnesses such as congestive heart failure, atrial fibrillation, and coronary artery disease can alter the
                       indication for valve replacement, as can the surgical need to correct other cardiac disease.


           3.2.3 Current and Historical Device Design

                       Artificial heart valve design has a long and colorful history, with more than 80 different versions of
                       valve being introduced since the 1950s (Vongpatanasin et al., 1996).  The two general types of
                       replacement valves, mechanical and biologic, each have their own set of indications, complications,
                       and performance factors. The mechanical valve can be further categorized into three major design
                       lines: caged-ball, single-tilting-disc, and bileaflet (Vongpatanasin et al., 1996). Caged-ball valves
                       have been largely supplanted by the more modern single-tilting-disc and bileaflet valves. Biologic
                       valves are divided based on the source of the tissue material, with the term bioprosthetic reserved for
                       valves constructed from nonliving, animal-source tissue. Homograft biologic valves are preserved
                       human aortic valves, and autografts are pulmonary valves surgically moved to the aortic location
                       within the same patient (Bonow et al., 2006). Heterograft bioprosthetic valves consist of porcine
                       heart valves or bovine pericardial tissue formed into a valve over a support structure (Vongpatanasin
                       et al., 1996). Because mechanical and bioprosthetic valves have different design considerations, the
                       categories are discussed separately.
                       Mechanical Valves.  The assorted mechanical valve designs use different approaches to achieve the
                       same functional goal. Caged-ball valves use a free-floating polymeric sphere constrained by a metal
   76   77   78   79   80   81   82   83   84   85   86